Trastuzumab Recruiting Phase 1 Trials for Stage IV Breast Cancer / Stage IIIB Breast Cancer / Stage IIIA Breast Cancer / Recurrent Breast Carcinoma / HER2 Positive Breast Carcinoma / Stage IIIC Breast Cancer / Stage III Breast Cancer Treatment

RecruitingTreatment1 IdentifierTitleDrugs
NCT033643484-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer